Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

670 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 670 results

Testing effectiveness (Phase 2)Study completedNCT01265498
What this trial is testing

The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 283
Not applicableStudy completedNCT04454463
What this trial is testing

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Who this might be right for
Liver Diseases
Johns Hopkins Bloomberg School of Public Health 1,649
Early research (Phase 1)Study completedNCT03976687
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis Patients

Who this might be right for
NASH - Nonalcoholic SteatohepatitisHealthy
Enyo Pharma 16
Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Testing effectiveness (Phase 2)Study completedNCT03576755
What this trial is testing

Spironolactone Therapy In Young Women With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
University of California, San Francisco 20
Not applicableLooking for participantsNCT05439226
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableStudy completedNCT02880189
What this trial is testing

EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity

Who this might be right for
ObesityNon-Alcoholic Steatohepatitis
Mayo Clinic 21
Not applicableStudy completedNCT04165343
What this trial is testing

Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
University of California, Davis 81
Not applicableStudy completedNCT03683589
What this trial is testing

De Novo Lipogenesis in Severity of NAFLD

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisBariatric Surgery Candidate+1 more
University of Missouri-Columbia 49
Not applicableUnknownNCT03602573
What this trial is testing

Liver Fibrosis in Peri-menopausal Women

Who this might be right for
Nonalcoholic SteatohepatitisLiver FibrosesMenopause
Chang Gung Memorial Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01237119
What this trial is testing

Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
University of Birmingham 52
Not applicableLooking for participantsNCT07248371
What this trial is testing

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

Who this might be right for
Metabolic Syndrome (MetS)Obesity & OverweightCardiovascular Diseases (CVD)+3 more
Chang Gung Memorial Hospital 6,266
Not applicableStudy completedNCT04494360
What this trial is testing

Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD

Who this might be right for
Healthy
Janssen Research & Development, LLC 830
Testing effectiveness (Phase 2)Study completedNCT05623189
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes
HighTide Therapeutics (Hong Kong) Limited 218
Not applicableUnknownNCT03648086
What this trial is testing

Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Zhongshan Hospital Xiamen University 30
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableActive Not RecruitingNCT05986916
What this trial is testing

Accurate Point of Care Liver Disease Diagnostics

Who this might be right for
NAFLDNonalcoholic Fatty Liver
University of California, San Diego 50
Not applicableStudy completedNCT02290106
What this trial is testing

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

Who this might be right for
ObesityFatty Liver, Nonalcoholic
Massachusetts General Hospital 50
Not applicableStudy completedNCT00583999
What this trial is testing

The Role of Leptin Receptors in NASH

Who this might be right for
Nonalcoholic SteatohepatitisMetabolic Syndrome
University of California, Davis 104
Next Page